| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1117804B1 Mutants of op-1 |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1069909B1 Conjugate vaccines for the prevention of dental caries |
| 06/13/2007 | EP1037989B1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/13/2007 | EP1037909B1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |
| 06/13/2007 | EP1012304B1 Component of bromelain |
| 06/13/2007 | EP1011457B1 Stent lining |
| 06/13/2007 | EP0986572B2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 06/13/2007 | EP0975354B1 Ligand/lytic peptide compositions and methods of use |
| 06/13/2007 | EP0954330B1 Intestinal trefoil proteins |
| 06/13/2007 | EP0948536B1 A g protein-coupled receptor with an enlarged extracellular domain |
| 06/13/2007 | EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors |
| 06/13/2007 | EP0889972B1 Use of the determination of polymorphims in the promoter region of the TGF-beta 1 gene in diagnosis |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | EP0815136B1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | EP0788546B9 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 06/13/2007 | CN1981033A Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 06/13/2007 | CN1980952A Multimerised HIV fusion inhibitors |
| 06/13/2007 | CN1980951A 抗微生物多肽 Antimicrobial peptides |
| 06/13/2007 | CN1980948A Treatment of diseases and conditions mediated by increased phosphorylation |
| 06/13/2007 | CN1980699A Treatment methods utilizing albumin-binding proteins as targets |
| 06/13/2007 | CN1980698A Modulation of immunoglobulin production and atopic disorders |
| 06/13/2007 | CN1980696A Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients |
| 06/13/2007 | CN1980694A Use of gelsolin to treat infections |
| 06/13/2007 | CN1980690A Malignant tumor local infiltration inhibitor containing batroxobin |
| 06/13/2007 | CN1980689A Diaminooxidase-containing pharmaceutical compositions |
| 06/13/2007 | CN1980688A Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections |
| 06/13/2007 | CN1980687A 清蛋白融合蛋白 Albumin fusion proteins |
| 06/13/2007 | CN1980686A Antiobesity drug |
| 06/13/2007 | CN1980685A Biomarkers of resistance to HIV-infections in humans and biological applications thereof |
| 06/13/2007 | CN1980684A Methods and compositions for the treatment of inflammation |
| 06/13/2007 | CN1980649A Methods and reagents for the treatment of immunoinflammatory disorders |
| 06/13/2007 | CN1980641A Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1 |
| 06/13/2007 | CN1980640A Oligonucleotide-containing microspheres, manufacture and delivery thereof |
| 06/13/2007 | CN1978645A Human hNIF3 s gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978644A Human hNGT gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978643A Human hMSC gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978466A Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 06/13/2007 | CN1978464A Ray angio-genesis inhibiting factor I separating, purifying and its N end aminoacid sequence |
| 06/13/2007 | CN1978463A Mesenchymal stem cell affinity peptide screening and use |
| 06/13/2007 | CN1978462A Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
| 06/13/2007 | CN1977976A Method for treating nerve injury and vector construct for the same |
| 06/13/2007 | CN1977973A Use of oligo chitosan and its derivative as anti HIV-1 polypeptide drug carrier |
| 06/13/2007 | CN1977969A Drug injection of recombinant human erythropoietin |
| 06/13/2007 | CN1977968A Anti-fatigue function of novel compound locust polypeptide |
| 06/13/2007 | CN1977967A Injection preparation and use |
| 06/13/2007 | CN1977943A Topical burn composition |
| 06/13/2007 | CN1977828A Injection preparation and use |
| 06/13/2007 | CN1977779A Vascular stent with drug-eluting |
| 06/13/2007 | CN1321183C Polypeptide with Beta-lactamase inhibiting activity and its coded DNA |
| 06/13/2007 | CN1321134C Hetergeneous product of bio-active protein and its preparing process |
| 06/13/2007 | CN1321133C Human blood high density lipoprotein and its preparation method and use |
| 06/13/2007 | CN1321132C Batyl active peptide, preparation and therepic use thereof |
| 06/13/2007 | CN1321131C Pig Ghrelin derivative, its encoding gene and application |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1320929C Agents for gene therapeutic for cerebrovascular disorders |
| 06/13/2007 | CN1320922C Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 06/12/2007 | US7230155 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders |
| 06/12/2007 | US7230094 Neutral sphingomyelinase antisense ribozyme and uses thereof |
| 06/12/2007 | US7230086 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230081 Interferon gamma conjugates |
| 06/12/2007 | US7230079 purified anti-allergic royal jelly protein; foods, cosmetics, pharmaceuticals |
| 06/12/2007 | US7230078 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/12/2007 | US7230075 Coccidiosis poultry vaccine |
| 06/12/2007 | US7230073 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 06/12/2007 | US7229978 Chloromethylating an alcohol or phenol, especially camptothecin, propofol, etoposide, vitamin E, or cyclosporin A, and reacting the product with phosphoric acid in the presence of a base in a suitable polar aprotic solvent |
| 06/12/2007 | US7229976 Modulation of forkhead box O1A expression |
| 06/12/2007 | US7229974 Used to diagnose or treat cancer, restenosis, a disease caused by a virus, a disease affected by integrins or cell-cell adhesion receptor or a disease triggered by diffusible factors |
| 06/12/2007 | US7229971 Regulation of biodegradability of composite biomaterials |
| 06/12/2007 | US7229970 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/12/2007 | US7229969 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 06/12/2007 | US7229968 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 06/12/2007 | US7229967 Bubbling oxygen gas through aqueous albumin to form a composition useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood. |
| 06/12/2007 | US7229966 Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| 06/12/2007 | US7229965 Use of growth hormone in low dose |
| 06/12/2007 | US7229964 Insulin derivatives |
| 06/12/2007 | US7229963 Using enzyme inhibitors of histone deacetylase to enhance progenitor cell differentiation; regenerative medicine and treatment of nervous system disorders |
| 06/12/2007 | US7229962 A fusion protein is dimerized with two soluble extracellular domains of proteins by intermolecular disulfide bonds, formation/s-s/; improved stability and therapeutic effects |
| 06/12/2007 | US7229961 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 06/12/2007 | US7229960 Administering a non-phosphorylated tripeptides |
| 06/12/2007 | US7229959 Supplemented fibrin matrix delivery systems |
| 06/12/2007 | US7229809 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 06/12/2007 | US7229793 nucleic acid sequence encoding a signal peptide; a nucleic acid sequence which encodes the pro-region of a somatostatin or a functional fragment or variant thereof; pro-region somatostatin/peptide fusions reduce degradation of small peptides such as glucagon-like peptide, thereby increasing the half-life |
| 06/12/2007 | US7229788 Mutating one or more of the amino acid residues of the amino acid sequence, in the tropoelastin, so that susceptibility of the tropoelastin to cleavage by thrombin, kallikrein or serum is reduced |
| 06/12/2007 | US7229773 Screening method for apoptosis-suppressing or-promoting substance |
| 06/12/2007 | US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control |
| 06/12/2007 | US7229651 Grape seed extract, a grape skin extract, and a digestive enzyme, flavonoids; for inhibiting platelet aggregation |
| 06/12/2007 | US7229638 Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons |
| 06/12/2007 | US7229635 Pharmacotherapeutic process and composition for central nervous system disorders |
| 06/12/2007 | US7229634 Engineered proteins, and methods of making and using |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229626 Administering Clostridial neurotoxin, wherein the Clostridial neurotoxin is administered to an intracranial site which is associated with the symptom of the neuropsychiatric disorder, thereby alleviating the symptom of the neuropsychiatric disorder |
| 06/12/2007 | US7229623 Her-2/neu fusion proteins |